Regarding the role of HER2 overexpression in cancer metabolism, SCC74B cells showed greater modulation in NAD(P)H binding activity while SCC74A cells showed greater modulation of NAD(P)H intensity in response to metabolic treatments of FCCP and rotenone. This evidence concerns the gene ERBB2 and cancer.